TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Enorama Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
1,376
|
6,477
|
10,763 |
| Financial expenses |
3,636
|
1,975
|
782 |
| Earnings before taxes |
-45,194
|
-39,757
|
-27,055 |
| EBITDA |
-39,082
|
-35,881
|
-24,926 |
| Total assets |
34,833
|
46,086
|
49,671 |
| Current assets |
13,133
|
11,116
|
21,854 |
| Current liabilities |
10,351
|
11,754
|
11,389 |
| Equity capital |
19,793
|
29,819
|
20,825 |
| - share capital |
6,477
|
1,382
|
1,171 |
| Employees (average) |
5
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
56.8%
|
64.7%
|
41.9% |
| Turnover per employee |
275
|
720
|
1,076 |
| Profit as a percentage of turnover |
-3284.4%
|
-613.8%
|
-251.4% |
| Return on assets (ROA) |
-119.3%
|
-82.0%
|
-52.9% |
| Current ratio |
126.9%
|
94.6%
|
191.9% |
| Return on equity (ROE) |
-228.3%
|
-133.3%
|
-129.9% |
| Change turnover |
-5,561
|
-3,962
|
8,670 |
| Change turnover % |
-80%
|
-38% | |
| Chg. No. of employees |
-4
|
-1
|
3 |
| Chg. No. of employees % |
-44%
|
-10% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.